$RVYL
RYVYL Inc.

2023 Q3 Form 10-Q Financial Statement

#000118518523000842 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $17.48M $14.85M
YoY Change 64.45% 113.18%
Cost Of Revenue $10.80M $8.725M
YoY Change 152.96% 110.6%
Gross Profit $6.680M $6.124M
YoY Change 5.03% 116.96%
Gross Profit Margin 38.22% 41.24%
Selling, General & Admin $7.072M $9.960M
YoY Change 24.51% 31.83%
% of Gross Profit 105.87% 162.64%
Research & Development $1.315M $1.184M
YoY Change -8.81% -38.33%
% of Gross Profit 19.69% 19.33%
Depreciation & Amortization $37.50K $39.61K
YoY Change 6.49% 15.33%
% of Gross Profit 0.56% 0.65%
Operating Expenses $9.044M $11.77M
YoY Change -4.02% 1.41%
Operating Profit -$2.364M -$5.641M
YoY Change -22.82% -35.74%
Interest Expense $4.200M -$4.840M
YoY Change 363.08% -371.91%
% of Operating Profit
Other Income/Expense, Net -$624.0K -$6.360M
YoY Change
Pretax Income -$2.988M -$12.00M
YoY Change -80.26% -216.15%
Income Tax $128.0K $4.000K
% Of Pretax Income
Net Earnings -$3.116M -$12.01M
YoY Change -79.46% -215.32%
Net Earnings / Revenue -17.83% -80.85%
Basic Earnings Per Share -$0.60 -$2.33
Diluted Earnings Per Share -$0.60 -$2.33
COMMON SHARES
Basic Shares Outstanding 52.38M shares 51.34M shares
Diluted Shares Outstanding 5.232M shares 5.142M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.85M $13.20M
YoY Change 44.05% -54.64%
Cash & Equivalents $15.85M $13.17M
Short-Term Investments
Other Short-Term Assets $8.324M $6.982M
YoY Change 873.41% 510.09%
Inventory
Prepaid Expenses
Receivables $698.0K $649.0K
Other Receivables $8.324M $7.000M
Total Short-Term Assets $80.34M $73.86M
YoY Change 17.48% -12.98%
LONG-TERM ASSETS
Property, Plant & Equipment $1.660M $1.636M
YoY Change -2.48% -4.6%
Goodwill $26.75M $26.75M
YoY Change 0.48% 0.48%
Intangibles $5.678M $6.298M
YoY Change -74.65% -74.3%
Long-Term Investments $227.0K $900.0K
YoY Change -84.87%
Other Assets $1.826M $1.978M
YoY Change 881.52% 963.22%
Total Long-Term Assets $39.93M $41.56M
YoY Change -26.08% -24.29%
TOTAL ASSETS
Total Short-Term Assets $80.34M $73.86M
Total Long-Term Assets $39.93M $41.56M
Total Assets $120.3M $115.4M
YoY Change -1.75% -17.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $67.40M $58.40M
YoY Change 196.9% 67.74%
Accrued Expenses $580.0K $2.600M
YoY Change -3.33% 6.32%
Deferred Revenue
YoY Change
Short-Term Debt $15.00K $0.00
YoY Change 16.55%
Long-Term Debt Due $15.00K $15.00K
YoY Change 16.55%
Total Short-Term Liabilities $73.17M $66.04M
YoY Change 168.3% 68.5%
LONG-TERM LIABILITIES
Long-Term Debt $61.55M $66.94M
YoY Change 9561.87% 10200.05%
Other Long-Term Liabilities $3.567M $3.800M
YoY Change 224.27% 208.22%
Total Long-Term Liabilities $61.55M $66.94M
YoY Change 9561.87% 10200.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $73.17M $66.04M
Total Long-Term Liabilities $61.55M $66.94M
Total Liabilities $138.3M $136.8M
YoY Change 57.69% 37.04%
SHAREHOLDERS EQUITY
Retained Earnings -$122.6M -$119.5M
YoY Change 90.77% 143.38%
Common Stock $5.000K $51.00K
YoY Change -89.62% 16.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$24.69M -$21.38M
YoY Change
Total Liabilities & Shareholders Equity $120.3M $115.4M
YoY Change -1.75% -17.42%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$3.116M -$12.01M
YoY Change -79.46% -215.32%
Depreciation, Depletion And Amortization $37.50K $39.61K
YoY Change 6.49% 15.33%
Cash From Operating Activities $4.454M $6.750M
YoY Change -130.63% -77.22%
INVESTING ACTIVITIES
Capital Expenditures $58.00K $0.00
YoY Change -138.67% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$58.00K $0.00
YoY Change -95.54% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.000K -10.00K
YoY Change
NET CHANGE
Cash From Operating Activities 4.454M 6.750M
Cash From Investing Activities -58.00K 0.000
Cash From Financing Activities -1.000K -10.00K
Net Change In Cash 4.395M 6.740M
YoY Change -127.75% -76.72%
FREE CASH FLOW
Cash From Operating Activities $4.454M $6.750M
Capital Expenditures $58.00K $0.00
Free Cash Flow $4.396M $6.750M
YoY Change -130.55% -77.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34294
dei Entity Registrant Name
EntityRegistrantName
RYVYL INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-3962936
dei Entity Address Address Line1
EntityAddressAddressLine1
3131 Camino Del Rio North, Suite 1400
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92108
dei City Area Code
CityAreaCode
619
dei Local Phone Number
LocalPhoneNumber
-631-8261
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
RVYL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52382865 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13166000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13961000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50760000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
26873000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
111000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
82000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
649000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1156000 usd
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
842000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
9326000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
6982000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7427000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2305000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9798000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
73862000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
59215000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1636000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1696000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1978000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
197000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
26753000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
26753000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6298000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6739000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3985000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1533000 usd
CY2023Q2 us-gaap Investments
Investments
913000 usd
CY2022Q4 us-gaap Investments
Investments
1524000 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
41563000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
38442000 usd
CY2023Q2 us-gaap Assets
Assets
115425000 usd
CY2022Q4 us-gaap Assets
Assets
97657000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12792000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1630000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4445000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3662000 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2234000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1728000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
45607000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28912000 usd
CY2023Q2 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
15000 usd
CY2022Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
14000 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
584000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
255000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
358000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
534000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
66035000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36735000 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
66940000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
61735000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3833000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1109000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
136808000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
99579000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
82500000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
82500000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51963779 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51963779 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49727355 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49727355 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
51000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
49000 usd
CY2023Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
0 usd
CY2022Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96570000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96271000 usd
CY2023Q2 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
67000 usd
CY2022Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
0 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1525000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1596000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-119462000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99772000 usd
CY2023Q2 rvyl Shares To Be Returned
SharesToBeReturned
0 usd
CY2022Q4 rvyl Shares To Be Returned
SharesToBeReturned
68000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-21383000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1922000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115425000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97657000 usd
CY2023Q2 us-gaap Revenues
Revenues
14849000 usd
CY2022Q2 us-gaap Revenues
Revenues
6966000 usd
us-gaap Revenues
Revenues
26140000 usd
us-gaap Revenues
Revenues
11176000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
8725000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
4230000 usd
us-gaap Cost Of Revenue
CostOfRevenue
14903000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7010000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
6124000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
2736000 usd
us-gaap Gross Profit
GrossProfit
11237000 usd
us-gaap Gross Profit
GrossProfit
4166000 usd
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
33000 usd
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
527000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
108000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
668000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1184000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1920000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3119000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3858000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4055000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1354000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5508000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3146000 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2913000 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2712000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
5627000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
5096000 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
2989000 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
1168000 usd
us-gaap Professional Fees
ProfessionalFees
4792000 usd
us-gaap Professional Fees
ProfessionalFees
2672000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
-32000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1715000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
161000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1882000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
79000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
206000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
623000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2127000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1242000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2581000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
11765000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
11602000 usd
us-gaap Operating Expenses
OperatingExpenses
20557000 usd
us-gaap Operating Expenses
OperatingExpenses
20109000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5641000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8866000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9320000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15943000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1517000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1783000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3246000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5613000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2821000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
5582000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
5443000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
13172000 usd
CY2023Q2 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
-188000 usd
CY2022Q2 us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
0 usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
-188000 usd
us-gaap Gains Losses On Restructuring Of Debt
GainsLossesOnRestructuringOfDebt
0 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-757000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1657000 usd
CY2023Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-497000 usd
CY2022Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
26435000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-329000 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
18735000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
37000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
82000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1337000 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2531000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1447000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
235000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6360000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20881000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10653000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1390000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12001000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12015000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19973000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17333000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-77000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-12005000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
12092000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19982000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17335000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12005000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12092000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19982000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17335000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-398000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-71000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-398000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12018000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11694000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-20053000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-17733000 usd
CY2023Q2 rvyl Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.23
CY2022Q2 rvyl Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0.28
rvyl Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.39
rvyl Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.56
CY2023Q2 rvyl Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
51417099 shares
CY2022Q2 rvyl Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
42977461 shares
rvyl Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
51287902 shares
rvyl Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
31208102 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1922000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
31000 usd
CY2023Q1 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
294000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8037000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-9634000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
130000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
416000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
315000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12018000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-21383000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29468000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
126000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000 usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3237000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2110000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
167000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-29427000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-786000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
79000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1496000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
9826000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
12092000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
22707000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19982000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17335000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1242000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2581000 usd
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
67000 usd
us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
79000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
161000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1882000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
0 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
206000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5443000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
13172000 usd
rvyl Derecognition Upon Conversion Of Note Payable
DerecognitionUponConversionOfNotePayable
188000 usd
rvyl Derecognition Upon Conversion Of Note Payable
DerecognitionUponConversionOfNotePayable
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-329000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
18735000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1657000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-507000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
138000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7366000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1053000 usd
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-445000 usd
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-1018000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1781000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-35000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11161000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2269000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
782000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
732000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
506000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2349000 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
16695000 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
18914000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23129000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3095000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
661000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
28811000 usd
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0 usd
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
16000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45559000 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
3237000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
0 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-6000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9232000 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
18677000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23105000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33019000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-915000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40834000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89559000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63926000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55625000 usd
us-gaap Interest Paid
InterestPaid
2709000 usd
us-gaap Interest Paid
InterestPaid
3127000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
300000 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
2110000 usd
us-gaap Stock Issued1
StockIssued1
3000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
CY2022Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
28800000 usd
CY2022Q2 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
26000000 eur
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates</b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Reclassifications</b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations or cash flows.</p>
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
584000 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
255000 usd
CY2023Q2 rvyl Offering Value
OfferingValue
40000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
200000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1936000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1920000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
300000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
224000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1636000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1696000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
39605 usd
CY2022Q2 us-gaap Depreciation
Depreciation
34340 usd
us-gaap Depreciation
Depreciation
76065 usd
us-gaap Depreciation
Depreciation
67117 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
319627 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.29
CY2023Q2 us-gaap Goodwill
Goodwill
26753000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
26753000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10487000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-4189000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6298000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9762000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-3023000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6739000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
1200000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1239000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2002000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1844000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
992000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
148000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
73000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6298000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
319627 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.29
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
66955000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
61749000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
15000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
14000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
66940000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
61735000 usd
CY2021Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-11-05
CY2023Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
22703000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
391562 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12417 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
9702 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.24
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
369443 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.47
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
387916 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
369443 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.47
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
387916 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
319627 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.29
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q2 us-gaap Share Price
SharePrice
0.75
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
39413 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
39413 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
3.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
0 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
667277 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.2
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
131658 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.76
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
347537 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.53
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
319740 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.46
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
131658 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.76
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
86194 shares
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
548039 shares
CY2023Q2 us-gaap Property Subject To Or Available For Operating Lease Number Of Units
PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits
3 pure
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
45593 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
100000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
258656 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
198409 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
459535 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
357831 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.117 pure
us-gaap Net Income Loss
NetIncomeLoss
-19982000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17335000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
623000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
401000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1167000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1240000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1162000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
883000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
878000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5731000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1539000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4192000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
358000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3833000 usd
CY2023Q3 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
579393 usd
CY2023Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
800000 usd
CY2022Q3 us-gaap Deposits
Deposits
685000 eur
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2023Q2 us-gaap Revenues
Revenues
14849000 usd
CY2022Q2 us-gaap Revenues
Revenues
6966000 usd
us-gaap Revenues
Revenues
26140000 usd
us-gaap Revenues
Revenues
11176000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5641000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8866000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9320000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15943000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-12005000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
12092000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2127000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1242000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2581000 usd
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
34686000 usd
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
35187000 usd
CY2023Q2 us-gaap Assets
Assets
115425000 usd
CY2022Q4 us-gaap Assets
Assets
97657000 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001419275

Files In Submission

Name View Source Status
rvyl-20230630_pre.xml Edgar Link unprocessable
0001185185-23-000842-index-headers.html Edgar Link pending
0001185185-23-000842-index.html Edgar Link pending
0001185185-23-000842.txt Edgar Link pending
0001185185-23-000842-xbrl.zip Edgar Link pending
ex_559073.htm Edgar Link pending
ex_559074.htm Edgar Link pending
ex_559075.htm Edgar Link pending
ex_559076.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rvyl-20230630.xsd Edgar Link pending
rvyl-20230630_def.xml Edgar Link unprocessable
rvyl-20230630_lab.xml Edgar Link unprocessable
rvyl-20230630_cal.xml Edgar Link unprocessable
ryvyl20230630_10q.htm Edgar Link pending
Show.js Edgar Link pending
ryvyl20230630_10q_htm.xml Edgar Link completed